Clinical Observation on Dangfei Liganning Combined with Matrine in Treatment of Hepatic Fibrosis in 123 Cases

Qin Houji; He Yanzhuan; Zhou Yaonan; et al.

doi:10.13288/j.11-2166/r.2006.12.019

您当前的位置：

首页 >

文章列表页 >

Clinical Observation on Dangfei Liganning Combined with Matrine in Treatment of Hepatic Fibrosis in 123 Cases

更新时间：2021-11-17

- Clinical Observation on Dangfei Liganning Combined with Matrine in Treatment of Hepatic Fibrosis in 123 Cases
- Journal of Traditional Chinese Medicine Issue 12, Pages: 910-911(2006)
- 作者机构：
  
  1. 右江民族医学院附属医院感染疾病科
  2. 右江民族医学院附属医院感染疾病科广西壮族自治区百色市中山二路18号
  3. ,533000
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2006.12.019
  CLC： R259
- Published：2006
- 稿件说明：
移动端阅览
[1]覃后继,何延专,周耀南,陆春雷.当飞利肝宁联合苦参素抗肝纤维化123例临床观察[J].中医杂志,2006(12):910-911+914.

Qin Houji, He Yanzhuan, Zhou Yaonan, et al. Clinical Observation on Dangfei Liganning Combined with Matrine in Treatment of Hepatic Fibrosis in 123 Cases[J]. Journal of Traditional Chinese Medicine2006, (12): 910-911.
[1]覃后继,何延专,周耀南,陆春雷.当飞利肝宁联合苦参素抗肝纤维化123例临床观察[J].中医杂志,2006(12):910-911+914. DOI： 10.13288/j.11-2166/r.2006.12.019.

Qin Houji, He Yanzhuan, Zhou Yaonan, et al. Clinical Observation on Dangfei Liganning Combined with Matrine in Treatment of Hepatic Fibrosis in 123 Cases[J]. Journal of Traditional Chinese Medicine2006, (12): 910-911. DOI： 10.13288/j.11-2166/r.2006.12.019.

摘要

目的:观察当飞利肝宁联合苦参素治疗乙型肝炎病毒感染的不同肝病患者肝纤维化的疗效。方法:采用RIA法

分别检测应用当飞利肝宁联合苦参素治疗前和治疗6个月后123例不同肝病患者血清肝纤维化指标含量

另31例慢性乙型肝炎患者采用单一苦参素治疗

用同法检测其血清肝纤维化指标含量。结果:123例不同肝病患者中乙型肝炎病毒携带者、慢性乙型肝炎、代偿期肝硬化患者治疗后与治疗前比较肝纤维化指标明显下降（P<0.05或P<0.01）

失代偿期肝硬化患者治疗后各项指标无明显变化（P>0.05）。当飞利肝宁联合苦参素治疗后

慢性乙型肝炎患者的肝纤维化指标含量明显下降（P<0.01）

且较单一苦参素治疗疗效更好（P<0.05）。结论:当飞利肝宁联合苦参素治疗可使乙型肝炎病毒携带者、慢性乙型肝炎、代偿期肝硬化患者血清肝纤维化指标含量显著下降

阻止或延缓失代偿期肝硬化患者病变进程

且抗慢性乙型肝炎纤维化疗效明显优于单用苦参素。

Abstract

Objective:To observe the therapeutic effect of Dangfei Liganning combined with Matrine on hepatic fibrosis in patients of different hepatic diseases infected by hepatitis B virus.Methods:Determine serum hepatic fibrosis indexes before and 6 months after treatment with RIA in 123 cases of different hepatic diseases treated with Dangfei Liganning combined with Matrine

and 31 cases of chronic hepatitis B treated with simple Matrine.Results:Of the 123 cases of different hepatic diseases

hepatic fibrosis indexes in hepatitis B virus carriers

chronic hepatitis B patients and the patients of liver cirrhosis at compensatory phase decreased significantly（P<0.05 or P<0.01） after treatment

but the indexes in the patients of liver cirrhosis at decompensatory phase did not significantly change（P>0.05）.After treatment with Dangfei Liganning combined with Matrine

the hepatic fibrosis indexes in the patients of chronic hepatitis B significantly decreased（P<0.01） with a better therapeutic effect than that of simple Matrine（P<0.05）.Conclusion:Dangfei Liganning combined with Matrine can significantly decrease hepatic fibrosis indexes in hepatitis B virus carriers

patients of chronic hepatitis B and liver cirrhosis at compensatory phase

arresting or delaying development of lesion in the patient of liver cirrhosis at the decompensatory phase

with a significantly better therapeutic effect than simple Matrine.

关键词

Keywords

references

查看原文

Views

144

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

LI Guolie's Experience in Treating Orthostatic Hypotension from the Perspective of "Raising the Clear and Directing the Turbid Downward"

Efficacy and Economic Evaluation of Weishi Qingjin Formula （苇石清金方）in the Treatment of Adult Community-Acquired Pneumonia with Phlegm-Heat Obstructing the Lung Syndrome：A Multicenter Retrospective Real-World Cohort Study

The Philosophy and Practical Pathway of "Dao （道）-Shen （神）-Formula" in Traditional Chinese Medicine

Clinical Efficacy and Economic Evaluation of 1293 Non-Severe Adult Patients with Community-Acquired Pneumonia Treated by the Jiangsu Traditional Chinese Medicine Diagnosis and Treatment Protocol for Dominant Diseases：A Multicenter，Retrospective Real-World Cohort Study

Similarities and Differences between Myofascial Trigger Points and Sinew Knot：from the Perspective of the Channel Sinew Theory

Related Author

No data

Related Institution

No data

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰